These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1992325)

  • 41. The role of immunoglobulin in bone marrow transplantation.
    Saral R
    Transplant Proc; 1991 Aug; 23(4):2128-32. PubMed ID: 1871829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transplantation of T lymphocyte depleted bone marrow to prevent graft-versus-host disease: its implications for fetal liver transplantation.
    Champlin RE; Mitsuyasu RT; Gale RP
    Prog Clin Biol Res; 1985; 193():315-25. PubMed ID: 3911215
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
    Schwinghammer TL; Bloom EJ
    Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Monitoring lymphocyte activity in the peripheral blood of patients after bone marrow transplantation].
    Hrabánek J; Lukásová M; Chudomel V; Smetana K
    Cas Lek Cesk; 1994 Jan; 133(3):80-2. PubMed ID: 8137377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation.
    Fehir KM; Decker WA; Samo T; Young JB; Lederer E; Lawrence EC
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3107-9. PubMed ID: 2539691
    [No Abstract]   [Full Text] [Related]  

  • 46. Letter: Transplantation and burns.
    Koumans RK
    Lancet; 1975 May; 1(7917):1190. PubMed ID: 48805
    [No Abstract]   [Full Text] [Related]  

  • 47. Graft-versus-host disease.
    Denman AM
    Br Med J (Clin Res Ed); 1982 Oct; 285(6350):1226-7. PubMed ID: 6812816
    [No Abstract]   [Full Text] [Related]  

  • 48. What is your diagnosis? Graft-versus-host disease.
    Elston DM
    Cutis; 2005 Oct; 76(4):230, 236-8. PubMed ID: 16315558
    [No Abstract]   [Full Text] [Related]  

  • 49. [Bone marrow transplantation in children].
    Hermann J
    Kinderkrankenschwester; 1993 Mar; 12(3):121-3. PubMed ID: 8489949
    [No Abstract]   [Full Text] [Related]  

  • 50. Chronic graft-versus-host disease.
    Sullivan KM
    Cancer Treat Res; 1990; 50():79-98. PubMed ID: 1976359
    [No Abstract]   [Full Text] [Related]  

  • 51. Oral administration of IgG in marrow transplant recipients.
    Copelan EA; Bechtel T; Featheringham NC; Grose MM; Sedmak DD; Kapoor N; Tutschka PJ
    Drug Intell Clin Pharm; 1988 Nov; 22(11):912. PubMed ID: 3069429
    [No Abstract]   [Full Text] [Related]  

  • 52. Stability of normal human IgG in saline and glycine solutions.
    Patterson MR; Smith JK
    Vox Sang; 1974; 26(6):560-4. PubMed ID: 4854376
    [No Abstract]   [Full Text] [Related]  

  • 53. Commentary: Applying a causal road map in settings with time-dependent confounding.
    Petersen ML
    Epidemiology; 2014 Nov; 25(6):898-901. PubMed ID: 25265135
    [No Abstract]   [Full Text] [Related]  

  • 54. Collection and handling of bone marrow suspensions for intravenous use.
    BOYUM A
    Scand J Clin Lab Invest; 1962; 14():419-24. PubMed ID: 13872225
    [No Abstract]   [Full Text] [Related]  

  • 55. Noncomparability among IgG products.
    McCue JP; Johnson AJ
    Transfusion; 1986; 26(5):489. PubMed ID: 3765049
    [No Abstract]   [Full Text] [Related]  

  • 56. Removal of tumour cells from bone marrow: overview.
    Bron D; Stryckmans P
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):163-6. PubMed ID: 2649373
    [No Abstract]   [Full Text] [Related]  

  • 57. Comment on undegraded human 7S-immunoglobulin for intravenous use.
    Wadsworth C
    Vox Sang; 1976 Nov; 31(5):394-400. PubMed ID: 1007163
    [No Abstract]   [Full Text] [Related]  

  • 58. Factors affecting the production of intravenous immunoglobulin.
    Matejtschuk P; More J
    Biochem Soc Trans; 1990 Apr; 18(2):309-10. PubMed ID: 2116339
    [No Abstract]   [Full Text] [Related]  

  • 59. Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation.
    Siadak MF; Kopecky K; Sullivan KM
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):53-7. PubMed ID: 8033436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous IgG to prevent graft-versus-host disease after bone marrow transplantation.
    N Engl J Med; 1991 Feb; 324(9):631-3. PubMed ID: 1992325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.